Skip to main content

Cancer Research Archives

Study examines new breast cancer drug combination

Apr. 20, 2017—A study led by Vanderbilt-Ingram Cancer Center (VICC) investigators suggests a drug combination which includes a PDK1 protein blocker may be more effective for breast cancer that has become resistant to cyclin-dependent kinase (CDK4/6) targeted therapy.

Read more

Reporter


V Foundation grants bolster cancer initiatives

Nov. 17, 2016—Two Vanderbilt-Ingram Cancer Center (VICC) investigators have earned grant awards from The V Foundation for Cancer Research, continuing the foundation’s support for innovative cancer research initiatives at VICC.

Read more

Reporter


In search of new cancer targets

Sep. 9, 2016—Vanderbilt researchers developed a new algorithm to find clinically targetable gene rearrangements in cancers.

Read more

Health and Medicine Reporter Research


New breast cancer driver

Aug. 26, 2016—Vanderbilt investigators have demonstrated that a certain protein complex drives tumor progression in aggressive breast cancers.

Read more

Health and Medicine Reporter Research


Switching breast cancer off

Apr. 14, 2016—Signaling by a receptor that is overexpressed in aggressive forms of breast cancer has been linked to glutamine metabolism, suggesting new anti-cancer therapeutic targets.

Read more

Health and Medicine Reporter Research


Overcoming lung cancer drug resistance

Feb. 10, 2016—Vanderbilt investigators have discovered a way to overcome the resistance of some lung cancers to certain targeted therapies, which could lead to more effective treatments for lung cancer patients.

Read more

Health and Medicine Reporter Research


Nominations sought for 2016 Mary Kay Foundation Cancer Research Grant

Nov. 13, 2015—Vanderbilt University may nominate one candidate for the Mary Kay Foundation Translational Cancer Research Grant program for 2016.

Read more

myVU myVU Take Note


VUMC submission opportunity: 2015 V Scholar Grant for Cancer Research (revised)

Feb. 12, 2015—The V Scholar Award supports young tenure-track faculty to begin their cancer research career.

Read more

External Story myVU myVU Take Note


VUMC submission opportunity: 2015 Translational Grant/V Foundation (revised)

Feb. 12, 2015—Vanderbilt may nominate one candidate for the V Foundation 2015 Translational Grant.

Read more

External Story myVU myVU Take Note


Gene profile predicts metastasis

Feb. 9, 2015—A specific gene expression profile represents a novel, biologically relevant “signature” for identifying colon cancers with high risk of metastatic recurrence, Vanderbilt researchers have found.

Read more

Health and Medicine Reporter Research


Study tracks combination therapy to treat melanoma

Jan. 8, 2015—Melanoma is the most lethal form of skin cancer, with high mortality rates. While new drugs have been approved to treat the disease, patients nearly always develop resistance to the therapies and the cancer advances.

Read more

Health and Medicine Reporter Research


Immune cell activity and melanoma

Nov. 6, 2014—The activity of a certain factor in immune cells is essential for an anti-tumor response, emphasizing the need to consider the effects of anti-cancer therapies on immune cells.

Read more

Health and Medicine Reporter Research


Page 1 of 212